Indivior Pharmaceuticals, Inc. (INDV)
Makes prescription medications to treat opioid addiction and dependency disorders.
$40.39+0.01%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+91.9%
The outlook
Indivior trades at $40.39 with strong analyst support—the consensus leans "Strong Buy" with an average price target about 26% above current levels. The stock sits well above its 50- and 200-day moving averages and is near the upper end of its 52-week range, reflecting sustained upward momentum over the past year.
What’s behind the score
Analyst consensusStrong Buy — 1.3 avg of 6 analysts
Price trendAbove its 50- & 200-day averages
52-week range91% of the way from its 52-week low to high
Price targetAvg target +26% vs current price
Analyst price target
~12-month · 6 analysts$50.83average target+25.9% vs now
Now $40.39
Low $46.00High $59.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$4.77B
52-wk high
$42.81
52-wk low
$16.99
50-day avg
$38.85
200-day avg
$34.14
Trailing P/E
20.7